Atlas Trials

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Clinical trial NCT01939574 · UNKNOWN

Trial details

NCT number
NCT01939574
Sponsor
Shandong Cancer Hospital and Institute
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2013-08-01
Primary completion
2016-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.